The drug pricing program reveals systemic disparities in healthcare access and begins to address healthcare issues, ...
In just 10 years, annual 340B purchases grew more than 700%, from $7.5 billion in 2013 to $53.7 billion in 2022. Factors underlying this growth include. Exponential growth in participation by non ...
Fortunately, the 340B drug prescription program helps hospitals control costs and care for underserved communities by providing discounts on skyrocketing drug prices. Claims that the benefits of ...
In their joint lawsuit, Amgen, Eli Lilly and Company, and UCB claim several Nevada STD clinics were unlawfully qualified for the federal drug discount program, 340B, giving them access to millions ...
An Elon Musk-backed group is running attack ads against Republican lawmakers who support the 340B drug pricing program, which aids hospitals treating low-income patients. The ads claim the program ...